Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery

British Journal of Pharmacology

Volumn 146, Issue 3, 2005, Pages 419-424

  Molero, Laura ^a   López Farré, Antonio ^a   Mateos Cáceres, Petra J ^a   Fernández Sánchez, Ruth ^a   Maestro, María Luisa ^a   Silva, Jacobo ^a   Rodríguez, Enrique ^a   Macaya, Carlos ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Acute myocardial infarction; Clopidogrel; Coronary disease; Inflammation; Platelet activation

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; CD40 LIGAND; CLOPIDOGREL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PADGEM PROTEIN; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE DURATION; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INFLAMMATION; ISOLATED ORGAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIGATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RABBIT; SURGICAL TECHNIQUE; TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CD40 LIGAND; CORONARY VESSELS; DISEASE MODELS, ANIMAL; MALE; MYOCARDIAL ISCHEMIA; P-SELECTIN; PLATELET AGGREGATION INHIBITORS; RABBITS; THROMBOPLASTIN; TICLOPIDINE;

EID: 27144559270     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706340     Document Type: Article

References (32)

1. 111In-labeled platelet accumulation in infarcted myocardium. J. Cardiovasc. Pharmacol., 7, 906-912.
2. BIASUCCI, L.M., LIUZZO, G., GRILLO, R.L., CALIGIURI, G., REBUZZI, A.G., BUFFON, A., SUMMARIA, F., GINNETTI, F., FADDA, G. & MASERI, A. (1999). Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation, 99, 855-860.
3. DAVIES, M.J. & THOMAS, A. (1984). Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N. Engl. J. Med., 310, 1137-1140.
4. DE MIGUEL, L.S., JIMENEZ, A., MONTON, M., FARRE, J., DEL MAR ARRIERO, M., RODRIGUEZ-FEO, I.A., GARCIA-CAÑETE, J., RICO, L., GOMEZ, J., NUÑEZ, A., CASADO, S. & FARRE, A.L. (2000). A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function. Eur. J. Clin. Invest., 30, 811-817.
5. EIKELBOOM, J.W. & ANAND, S. (2003). Antiplatelet agents in acute coronary syndromes. Semin. Vasc. Med., 3, 403-414.
6. GAWAZ, M., NEUMANN, F.J., DICKFELD, T., KOCH, W., LAUGWITZ, K.L., ADELSBERGER, H., LANGENBRINK, K., PAGE, S., NEUMEIER, D., SCHOMIG, A. & BRAND, K. (1998). Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation, 98, 1164-1171.
7. HAKKINEN, T., KARKOLA, K. & YLA-HERTTUALA, S. (2000). Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions* Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows. Arch., 437, 396-405.
8. HERAULT, J.P., DOL, F., GAICH, C., BERNAT, A. & HERBERT, J.M. (1999). Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat. Thromb. Haemost., 81, 957-960.
9. HERBERT, J.M., DOL, F., BERNAT, A., FALOTICO, R., LALE, A. & SAVI, P. (1998). The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb. Haemost., 80, 512-518.
10. HUGHES, A., DAUNT, S., VASS, G. & WICKES, J. (1982). In vivo platelet activation following myocardial infarction and acute coronary ischemia. Thromb. Haemost., 48, 133-135.
11. KLINKHARDT, U., BAUERSACHS, R., ADAMS, J., GRAFF, J., LINDHOFF-LAST, E. & HARDER, S. (2003). Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin. Pharmacol. Ther., 73, 232-241.
12. KLINKHARDT, U., GRAFF, J. & HARDER, S. (2002). Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model. Clin. Pharmacol. Ther., 71, 176-185.
13. LINCOFF, A.M., KEREIAKES, D.J., MASCELLI, M.A., DECKELBAUM, L.I., BARNATHAN, E.S., PATEL, K.K., FREDERICK, B., NAKADA, M.T. & TOPOL, E.J. (2001). Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation., 104, 163-167.
14. LIUZZO, G., BIASUCCI, L.M., GALLIMORE, J.R., GRILLO, R.L., REBUZZI, A.G., PEPYS, M.B. & MASERI, A. (1994). The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N. Engl. J. Med., 331, 417-424.
15. LOPEZ-FARRE, A., RIESCO, A., DIGIUNI, E., MOSQUERA, J.R., CARAMELO, C., DE MIGUEL, L.S., MILLAS, I., DE FRUTOS, T., CERNADAS, M.R., MONTON, M., ALONSO, J. & CASADO, S. (1996). Aspirin-stimulated nitric oxide production by neutrophils after acute myocardial ischemia in rabbits. Circulation, 94, 83-87.
16. LOPEZ-FARRE, A., RODRIGUEZ-FEO, J.A., GARCIA-COLIS, E., GOMEZ, J., LOPEZ-BLAYA, A., FORTES, J., DE ANDRES, R., RICO, L. & CASADO, S. (2002). Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: effect of the alpha1-receptor blocker doxazosin. J. Hypertens., 20, 463-470.
17. MACKMAN, N. (1997). Regulation of the tissue factor gene. Thromb. Haemost., 78, 747-754.
18. MATEOS-CACERES, P.J., GARCIA-MENDEZ, A., FARRE, J., SANCHEZ DE MIGUEL, L., GOMEZ, J., DE ANDRES, R., RICO, L., ROMERO, J. & LOPEZ-FARRE, A. (2002). Prior aspirin use in unstable angina patients with modified plasma inflammatory markers and endothelial nitric oxide synthase in neutrophils. Eur. J. Clin. Invest., 32, 895-900.
19. MEHTA, S.R., YUSUF, S., PETERS, R.J., BERTRAND, M.E., LEWIS, B.S., NATARAJAN, M.K., MALMBERG, K., RUPPRECHT, H., ZHAO, F., CHROLAVICIUS, S., COPLAND, I., FOX, K.A. & Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators (2001). Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 358, 527-533.
20. MOLERO, L., FARRE, J., GARCIA-MENDEZ, A., MATEOS-CACERES, P.J., CARRASCO, C., MILLAS, I., NAVARRO, F., CORDOBA, M., CASADO, S. & LOPEZ-FARRE, A. (2003). Endothelin-1 induced proinflammatory markers in the myocardium and leukocytes of guinea-pig: role of glycopretin IIb/IIIa receptors. Cardiovasc. Res., 57, 109-118.
21. MORROW, D.A., RIFAI, N., ANTMAN, E.M., WEINER, D.L., MCCABE, C.H., CANNON, C.P. & BRAUNWALD, E. (1998). C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in myocardial infarction. J. Am. Coll. Cardiol., 31, 1460-1465.
22. NEUMANN, F.J., MARX, N., GAWAZ, M., BRAND, K., OTT, I., ROKITTA, C., STICHERLING, C., MEINL, C., MAY, A. & SCHOMIG, A. (1997). Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation, 95, 2387-2394.
23. NEUMANN, F.J., ZOHLNHÖFER, D., FAKHOURY, L., OTT, I., GAWAZ, M. & SCHÖMIG, A. (1999). Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J. Am. Coll. Cardiol., 34, 1420-1426.
24. O'BRIEN, P.J., LANDT, Y. & LADENSON, J.H. (1997). Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay. Clin. Chem., 43, 2333-2338.
25. QUINN, M.J., BHATT, D.L., ZIDAR, F., VIVEKANANTHAN, D., CHEW, D.P., ELLIS, S.G., PLOW, E. & TOPOL, E.J. (2004). Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Am. J. Cardiol., 93, 679-684.
26. RIDKER, P.M., RIFAI, N., PFEFFER, M., SACKS, F., LEPAGE, S. & BRAUNWALD, E. (2000). Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation, 101, 2149-2153.
27. SCHÖNBECK, U., VARO, N., LIBBY, P., BURING, J. & RIDKER, P.M. (2001). Soluble CD40L and cardiovascular risk in women. Circulation. 104, 2266-2268.
28. VAN GESTEL, M.A., HEEMSKERK, J.W., SLAAF, D.W., HEIJNEN, V.V., RENEMAN, R.S. & OUDE EGBRINK, M.G. (2003). In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability. Arterioscler. Thromb. Vasc. Biol., 23, 518-523.
29. WEBBER, A.A., REIMANN, S. & SCHROR, K. (1999). Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro. Br. J. Pharmacol., 126, 415-420.
30. YOSHIZUMI, M., PERRELLA, M.A., BURNETT JR, J.C. & LEE, M.E. (1993). Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res., 73, 205-209.
31. ZANINOTTO, M., ALTINIER, S., LACHIN, M., CARRARO, P. & PLEBANI, M. (1996). Fluoroenzymometric method to measure cardiac troponin I in sera of patients with myocardial infarction. Clin. Chem., 42, 1460-1466.
32. ZEIHER, A.M., SCHACHINGER, V., WEITZEL, S.H., WOLLSCHLAGER, H. & JUST, H. (1991). Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease. Circulation, 83, 1519-1525.